FAMILIAL CHYLOMICRONEMIA (TYPE-I HYPERLIPOPROTEINEMIA) DUE TO A SINGLE MISSENSE MUTATION IN THE LIPOPROTEIN-LIPASE GENE

被引:65
作者
AMEIS, D
KOBAYASHI, J
DAVIS, RC
BENZEEV, O
MALLOY, MJ
KANE, JP
LEE, G
WONG, H
HAVEL, RJ
SCHOTZ, MC
机构
[1] VET ADM WADSWORTH MED CTR, BLDG 113, ROOM 312, LOS ANGELES, CA 90073 USA
[2] UNIV CALIF LOS ANGELES, DEPT MED, LOS ANGELES, CA 90024 USA
[3] UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA
[4] UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA
[5] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA
关键词
POLYMERASE CHAIN REACTION; TRIGLYCERIDE;
D O I
10.1172/JCI115114
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Complete deficiency of lipoprotein lipase (LPL) causes the chylomicronemia syndrome. To understand the molecular basis of LPL deficiency, two siblings with drastically reduced postheparin plasma lipolytic activities were selected for analysis of their LPL gene. We used the polymerase chain reaction to examine the nine coding LPL exons in the two affected siblings and three relatives. DNA sequence analysis revealed a single nucleotide change compared with the normal LPL cDNA: a G --> A substitution at nucleotide position 680. This transition caused a replacement of glutamic acid for glycine at amino acid residue 142 of the mature LPL protein. Amino acid sequence comparisons of the region surrounding glycine-142 indicated that it is highly conserved among lipases from different species, suggesting a crucial role of this domain for the LPL structure. Expression studies of the mutant LPL cDNA in COS-7 cells produced normal amounts of enzyme mass. However, the mutated LPL was not catalytically active, nor was it efficiently secreted from the cells. This established that the Gly --> Glu substitution at amino acid 142 is sufficient to abolish enzymatic activity and to result in the chylomicronemia syndrome observed in these patients.
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 49 条
[1]
AMEIS D, 1990, J BIOL CHEM, V265, P6552
[2]
DETECTION AND CHARACTERIZATION OF THE HETEROZYGOTE STATE FOR LIPOPROTEIN-LIPASE DEFICIENCY [J].
BABIRAK, SP ;
IVERIUS, PH ;
FUJIMOTO, WY ;
BRUNZELL, JD .
ARTERIOSCLEROSIS, 1989, 9 (03) :326-334
[3]
LIPOPROTEIN-LIPASE BETHESDA - A SINGLE AMINO-ACID SUBSTITUTION (ALA-176-]THR) LEADS TO ABNORMAL HEPARIN BINDING AND LOSS OF ENZYMATIC-ACTIVITY [J].
BEG, OU ;
MENG, MS ;
SKARLATOS, SI ;
PREVIATO, L ;
BRUNZELL, JD ;
BREWER, HB ;
FOJO, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3474-3478
[4]
DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA [J].
BOBERG, J ;
CARLSON, LA .
CLINICA CHIMICA ACTA, 1964, 10 (05) :420-&
[5]
EVIDENCE THAT INSECT EMBRYOGENESIS IS REGULATED BY ECDYSTEROIDS RELEASED FROM YOLK PROTEINS [J].
BOWNES, M ;
SHIRRAS, A ;
BLAIR, M ;
COLLINS, J ;
COULSON, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1554-1557
[6]
HYPERTRIGLYCERIDEMIA ASSOCIATED WITH DEFICIENCY OF APOLIPOPROTEIN-C-II [J].
BRECKENRIDGE, WC ;
LITTLE, JA ;
STEINER, G ;
CHOW, A ;
POAPST, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (23) :1265-1273
[7]
THE MOLECULAR EVOLUTION OF GENES AND PROTEINS - A TALE OF 2 SERINES [J].
BRENNER, S .
NATURE, 1988, 334 (6182) :528-530
[8]
PLASMA TRIGLYCERIDE LEVELS AND CORONARY-DISEASE [J].
BRUNZELL, JD ;
AUSTIN, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (19) :1273-1275
[9]
BRUNZELL JD, 1983, J LIPID RES, V24, P147
[10]
BRUNZELL JD, 1983, J LIPID RES, V24, P12